Oculis Holding AG (Oculis), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced upcoming ...
Measures of Retinal Thickness Reflect CNS Pathology in MS In patients with multiple sclerosis (MS) without a history of optic neuritis, retinal measures reflect global central nervous system pathology ...
DALLAS — People with progressive multiple sclerosis (MS) show accelerated atrophy in inner and outer nuclear layers of the retina compared to those without the disease, offering important new pieces ...
Optic atrophy is a condition in which the optic nerve begins to deteriorate. The optic nerve is the nerve at the back of your eye that connects your eye to your brain, allowing you to see. There are a ...
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01 ...
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback